Nanoveu Ltd. (AU:NVU)
ASX:NVU
Top Page
Nanoveu Ltd.
(Sydney:NVU)
Select Model
Select Model
Rating:43Neutral
Price Target:
AU$0.06
▼(-35.56% Downside)
Action:ReiteratedDate:03/02/26
The score is held down primarily by weak financial performance—deep losses, negative gross profit, and ongoing cash burn—despite relatively low recent leverage. Technicals are also soft (below key moving averages with negative MACD), with oversold indicators only partially offsetting. Valuation is constrained by a negative P/E, reflecting the lack of profitability.
Positive Factors
Proprietary technology & B2B licensing model
Nanoveu's proprietary coatings and films and its B2B commercialization approach create durable competitive advantages: technology differentiation and licensing/supply channels let partners scale distribution and production, enabling recurring revenue opportunities and lower direct manufacturing capital requirements if adoption grows.
Negative Factors
Persistent negative cash flow
Operating and free cash flow have been negative in every reported year, showing a structural cash-burn problem. Durable dependence on external funding increases dilution and constrains reinvestment, making long-term execution and scaling contingent on successful funding or a rapid shift to positive cash conversion.
Read all positive and negative factors
Positive Factors
Negative Factors
Proprietary technology & B2B licensing model
Nanoveu's proprietary coatings and films and its B2B commercialization approach create durable competitive advantages: technology differentiation and licensing/supply channels let partners scale distribution and production, enabling recurring revenue opportunities and lower direct manufacturing capital requirements if adoption grows.
Read all positive factors
Nanoveu Ltd. (NVU) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$73.47M
Dividend YieldN/A
Average Volume (3M)9.28M
Price to Earnings (P/E)―
Beta (1Y)2.22
Revenue GrowthN/A
EPS GrowthN/A
CountryAU
Employees9
SectorTechnology
Sector Strength88
IndustrySoftware - Application
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,080,451,200
10 Day Avg. Volume7,199,231
30 Day Avg. Volume9,283,654
Financial Highlights & Ratios
PEG Ratio-0.19
Price to Book (P/B)5.64
Price to Sales (P/S)233.13
P/FCF Ratio-11.71
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Nanoveu Ltd. Business Overview & Revenue Model
Company Description
Nanoveu Limited, a technology company, develops and sells nanotechnology applications for consumer devices in the Americas and internationally. The company provides Nanoshield, an antiviral protector, which is available in various mobile phone scr...
How the Company Makes Money
Nanoveu makes money by commercializing its proprietary coating and film technologies through business-to-business arrangements, including supplying products and/or licensing its technology to partners that manufacture, distribute, or apply these c...
Nanoveu Ltd. Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
46
Neutral
Cash Flow
18
Very Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 297.58K | 6.87K | 102.54K | 159.51K | 781.21K |
| Gross Profit | -2.23M | 10.53K | 25.27K | 72.37K | 386.56K |
| EBITDA | -7.45M | -2.73M | -1.98M | -2.45M | -1.97M |
| Net Income | -7.42M | -2.85M | -2.16M | -2.67M | -2.32M |
Balance Sheet | |||||
| Total Assets | 13.55M | 1.32M | 513.00K | 427.33K | 2.75M |
| Cash, Cash Equivalents and Short-Term Investments | 1.81M | 498.30K | 73.07K | 248.14K | 2.01M |
| Total Debt | 341.96K | 126.33K | 225.26K | 300.00K | 986.68K |
| Total Liabilities | 1.46M | 983.58K | 622.40K | 700.75K | 1.17M |
| Stockholders Equity | 12.31M | 374.94K | -109.41K | -273.41K | 1.58M |
Cash Flow | |||||
| Free Cash Flow | -5.92M | -2.10M | -2.01M | -2.82M | -2.04M |
| Operating Cash Flow | -5.85M | -2.10M | -2.01M | -2.82M | -2.04M |
| Investing Cash Flow | -287.31K | -258.66K | 0.00 | 0.00 | 0.00 |
| Financing Cash Flow | 7.44M | 2.53M | 1.83M | 142.12K | 2.91M |
Nanoveu Ltd. Technical Analysis
Positive
0.09
Price Trends
0.07
Positive
0.08
Negative
0.08
Negative
Market Momentum
>-0.01
Negative
65.49
Neutral
80.42
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:NVU, the sentiment is Positive. The current price of 0.09 is above the 20-day moving average (MA) of 0.06, above the 50-day MA of 0.07, and above the 200-day MA of 0.08, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 65.49 is Neutral, neither overbought nor oversold. The STOCH value of 80.42 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:NVU.
Nanoveu Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
48 Neutral | AU$30.75M | -173.03 | -2.31% | ― | 2.98% | 93.55% | |
48 Neutral | AU$23.75M | -3.90 | -27.05% | ― | -3.43% | -40.65% | |
43 Neutral | AU$73.47M | -9.35 | -86.31% | ― | ― | ― | |
43 Neutral | AU$1.75M | -0.06 | -562.56% | ― | ― | ― | |
42 Neutral | AU$12.77M | -13.76 | 46.05% | ― | 7.32% | 67.11% | |
41 Neutral | AU$20.74M | -3.83 | -153.09% | ― | -48.98% | -12.82% |
* Technology Sector Average
AU:NVU
Nanoveu Ltd.
0.07
0.03
94.29%
AU:1TT
Wooboard Technologies Limited
0.01
0.00
0.00%
AU:VIG
Victor Group Holdings Ltd
0.04
-0.02
-32.79%
AU:AMX
Aerometrex Ltd.
0.25
-0.01
-3.85%
AU:XF1
Xref Ltd
0.06
-0.06
-51.67%
AU:ICE
iCetana Ltd.
0.04
0.02
129.41%
Nanoveu Ltd. Corporate Events
Nanoveu Showcases EMASS Strategy at Pitt Street Semiconductor Conference
Mar 24, 2026
Nanoveu Limited announced its participation in the Pitt Street Research Semiconductor Conference 2026, where Director and EMASS founder Dr Mohamed Sabry is outlining the company’s strategy for advancing its EMASS semiconductor business. The ...
Nanoveu cancels 21 million unvested performance rights after conditions lapse
Mar 5, 2026
Nanoveu Limited has reported changes to its capital structure following the lapse of certain performance rights. According to the company’s notification, 21,000,000 performance rights, classified as NVUAI, have ceased on 27 February 2026 aft...
Nanoveu Director Alfred Chong Sees 5 Million Performance Rights Expire
Mar 5, 2026
Nanoveu Ltd. has reported a change in the interests of director Alfred Chong, reflecting the expiry of a substantial portion of his performance rights. The update, lodged with the ASX, outlines that 5,000,000 performance rights held by Chong have ...
Nanoveu files 2025 corporate governance statement with ASX
Feb 27, 2026
Nanoveu Limited has lodged its Appendix 4G and confirmed that its corporate governance statement for the year ended 31 December 2025 is available on its website, in accordance with ASX Listing Rules. The statement, approved by the board, details t...
Nanoveu revenue surges but losses deepen in 2025 results
Feb 27, 2026
Nanoveu Limited reported a sharp increase in revenue from ordinary activities to A$298,000 for the year ended 31 December 2025, representing a 4,230% rise on the prior year. Despite this growth, the company’s net loss attributable to members...
Nanoveu Issues 56.9 Million Unquoted Options Expiring in 2029
Jan 27, 2026
Nanoveu Limited has notified the market of the issue of 56,931,835 unquoted options, each exercisable at $0.15 and expiring on 27 January 2029. The options, which form part of previously announced transactions and are not intended to be quoted on ...
Nanoveu Seeks ASX Quotation for 9.25 Million New Shares
Jan 27, 2026
Nanoveu Limited has applied to the ASX for quotation of 9,250,000 new ordinary fully paid shares under code NVU, with an issue date of 27 January 2026. The move increases the company’s quoted share capital, which may enhance liquidity in its...
Nanoveu Seeks ASX Quotation for 83.9 Million New Shares
Jan 27, 2026
Nanoveu Limited has applied for quotation on the ASX of 83,863,637 new fully paid ordinary shares, with an issue date of 27 January 2026. The additional securities, which stem from previously announced transactions, will expand the company’s...
Nanoveu Secures $7.38m in Strategic Placement and Option Exercises
Jan 27, 2026
Nanoveu Limited has completed the main tranche of its previously announced strategic placement, raising $7.38 million before costs via the issue of 83.9 million new shares at $0.088 each, accompanied by 41.9 million attaching options, within its e...
Nanoveu Plans Major Share and Option Issue to Raise Capital
Jan 19, 2026
Nanoveu Limited has notified the ASX of a proposed capital raising involving the issue of up to 85,227,274 new fully paid ordinary shares and 57,613,637 options, each with an exercise price of $0.15 and expiring in January 2029. The securities are...
Nanoveu Raises A$7.5m to Fast-Track Edge-AI Chip Commercialisation and Global Expansion
Jan 19, 2026
Nanoveu has secured firm commitments to raise A$7.5 million via an upsized share placement at A$0.088 per share, with free attaching options, from new and existing sophisticated and institutional investors, with directors also participating subjec...
Nanoveu Seeks Trading Halt Ahead of Capital Raising Announcement
Jan 15, 2026
Nanoveu Limited has requested an immediate trading halt in its securities on the ASX as it prepares to announce details of a proposed capital raising. The halt will remain in place until either the start of normal trading on 20 January 2026 or the...
Nanoveu Issues 250,000 Shares on Exercise of Unlisted Options
Jan 14, 2026
Nanoveu Limited has issued 250,000 new ordinary shares following the exercise of unlisted options, modestly expanding its share capital. The company confirmed the shares were issued without a prospectus in reliance on provisions of the Corporation...
Nanoveu Applies to List 250,000 New Ordinary Shares on ASX
Jan 14, 2026
Nanoveu Limited has applied to the ASX for the quotation of 250,000 new fully paid ordinary shares under the code NVU, with an issue date of 14 January 2026. The securities arise from the exercise or conversion of existing options or other convert...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.